| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
iii
|
|
|
|
Preface
|
Ernst J. Kuipers,
Guido N.J. Tytgat
|
S1
|
|
|
|
Necessity of phenotypic classification of Inflammatory Bowel Disease
Inflammatory bowel diseases (IBD) are classically divided in Crohn's disease (CD) and ulcerative colitis (UC). However, these two entities are still heterogeneous and a further classification in subph...
|
Edouard Louis,
Catherine Van Kemseke,
Catherine Reenaers
|
S2-S7
|
|
|
|
To what extent are genetics clinically useful?
The volume of research undertaken on the genetic susceptibility of inflammatory bowel diseases has been tremendous. International collaborative efforts which initiated in 1997 and have not stopped sin...
|
Séverine Vermeire
|
S8-S14
|
|
|
|
Novel developments in IBD-related sclerosing cholangitis
Primary sclerosing cholangitis is often regarded as an autoimmune disorder and occurs frequently in relation to inflammatory bowel disease. The ongoing fibro-obliterative process of the biliary tree e...
|
C.Y. Ponsioen
|
S15-S18
|
|
|
|
Novel development in extraintestinal manifestations and spondylarthropathy
The important co-existence of spondylarthritis (SpA) and inflammatory bowel disease (IBD) within the same individual suggests common etiopathogenic mechanisms. This is supported by intriguing similari...
|
M. De Vos,
P. Hindryckx,
D. Laukens
|
S19-S26
|
|
|
|
IBD-related carcinoma and lymphoma
Patients with inflammatory bowel disease (IBD) have an increased risk of developing colorectal cancer (CRC). Risk factors are extent and severity of colonic inflammation, concurrent primary sclerosing...
|
M.M.H. Claessen,
P.D. Siersema,
F.P. Vleggaar
|
S27-S38
|
|
